| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a7ac31dafa9b644bcbf73f79c4695dc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-02 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b95b6853c4d65dfdfefbdb9c4eb2de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c88a08584f4f1d2ef994faacc33959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a973acb72a5e2b85320c55b4b14baca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd208c0522fe084be98d1028f6759e37 |
| publicationDate |
2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3902802-A1 |
| titleOfInvention |
Compositions for inhibiting ubiquitin specific protease 1 |
| abstract |
This disclosure relates to modulating ubiquitin specific protease 1 (USP1) and provides novel chemical compounds useful as inhibitors of USP1, as well as various uses of these compounds. USP1 inhibiting compounds are useful in the treatment of diseases and disorders associated with USP1, such as cancer. |
| priorityDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |